Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
543.9 USD | +0.72% | +0.99% | +15.34% |
May. 15 | Transcript : Elevance Health, Inc. - Shareholder/Analyst Call | |
May. 02 | Factbox-Biggest cyber attacks in US healthcare sector | RE |
Financials (USD)
Sales 2024 * | 172B | Sales 2025 * | 182B | Capitalization | 126B |
---|---|---|---|---|---|
Net income 2024 * | 8.04B | Net income 2025 * | 9.09B | EV / Sales 2024 * | 0.84 x |
Net Debt 2024 * | 17.19B | Net Debt 2025 * | 13.67B | EV / Sales 2025 * | 0.77 x |
P/E ratio 2024 * |
15.8
x | P/E ratio 2025 * |
13.8
x | Employees | 104,900 |
Yield 2024 * |
1.15% | Yield 2025 * |
1.24% | Free-Float | 99.61% |
Latest transcript on Elevance Health, Inc.
1 day | +0.72% | ||
1 week | +0.99% | ||
Current month | +2.90% | ||
1 month | +7.28% | ||
3 months | +6.10% | ||
6 months | +17.32% | ||
Current year | +15.34% |
Managers | Title | Age | Since |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 23-09-05 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | Feb. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 13-09-30 | |
Director/Board Member | 55 | 22-10-31 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.22% | 17 M€ | +7.73% | - | |
2.36% | 1,085 M€ | +8.80% | - | |
2.07% | 8 M€ | 0.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 543.9 | +0.72% | 943,502 |
24-05-15 | 540 | +1.00% | 693,294 |
24-05-14 | 534.6 | -0.77% | 656,436 |
24-05-13 | 538.8 | -0.08% | 1,090,504 |
24-05-10 | 539.2 | +0.11% | 841,374 |
Delayed Quote Nyse, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.34% | 126B | |
+13.31% | 96.37B | |
-22.40% | 42.8B | |
+3.95% | 41.17B | |
-4.51% | 20.22B | |
-25.90% | 2.62B | |
-18.82% | 1.34B | |
-2.14% | 463M |
- Stock Market
- Equities
- ELV Stock